Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

Marc Tischkowitz(University of Cambridge), Gabriel Capellá(Institut Català d'Oncologia), Thierry Frébourg(Inserm), Stefan Aretz(University of Bonn), Marjolijn J. L. Ligtenberg(Radboud University Nijmegen), F. Caux(Assistance Publique – Hôpitaux de Paris), Kathleen Claes(Statistics Belgium), P. Wolkenstein(Université Paris-Est Créteil), Emma R. Woodward(Royal Manchester Children's Hospital), Chrystelle Colas(Institut Curie), Tanya M. Bisseling(Radboud University Nijmegen), Janet R. Vos(Radboud University Nijmegen), Martin Gotthardt, Isabel Spier(University of Bonn), Evelin Schröck(German Cancer Research Center), Rosalie E. Ferner(Guy's and St Thomas' NHS Foundation Trust), Nathalie Chabbert‐Buffet(Sorbonne Université), Robin De Putter(Ghent University Hospital), Virginie Bubien, Ian Stock(Cambridge University Hospitals NHS Foundation Trust), Eamonn R. Maher(Aston University), Bruce Poppe(Ghent University Hospital), Elke Holinski‐Feder(Garvan Institute of Medical Research), Eric Legius(Center for Human Genetics), Leo J. Schultze Kool(University of Alberta Hospital), Katherine Lachlan(Salisbury District Hospital), Thera P. Links(University Medical Center Groningen), Ritse M. Mann(Radboud University Nijmegen), Verena Steinke‐Lange(University of Cambridge), Rolf H. Sijmons(University Medical Center Groningen), Vincent Bours(University of Liège), Sjaak Pouwels(Elisabeth-TweeSteden Ziekenhuis), D. Gareth Evans(Manchester Academic Health Science Centre), Robert K. Semple(University of Edinburgh), Sophie Da Mota Gomes(Radboud University Nijmegen), Claude Houdayer(Inserm), Michel Longy(Université de Bordeaux), Marleen Kets(The Netherlands Cancer Institute), Rianne Oostenbrink(Leiden University Medical Center)
European Journal of Human Genetics
June 12, 2020
Cited by 141


Related Papers